ReNerve AGM Presentation
Filed with ASX · · 21 pages · English
Nature of Document: This presentation has been prepared and issued by ReNerve Ltd (Company) to provide general information about the Company. The information in this document is in summary form and should not be relied upon as a complete and accurate representation of any matters that a reader should consider in evaluating the Company. While management has taken every effort to ensure the accuracy
In the deck
Story so far
Earlier from Renerve
- ReNerve completes $3.2m capital raising
- Trading Halt
- Nerve Cuff approved for use in US DoD and VA hospitals
- ReNerve Clinical Study Expansion
- Q1 FY26 Activities Report and Appendix 4C
Later from Renerve
- Broader approval received in Hong Kong for Nerve Cuff
- ReNerve receives approval in Malaysia
- Q2 FY26 Activities Report and Appendix 4C
- 1HFY26 Appendix 4D and Half Year Report
- 1HFY26 Results Announcement
Follow Renerve into a list and get an email when it puts out news.
Follow Renerve